Skip to main content
VCbacked
Log inGet Started

ONL Therapeutics

Ann Arbor, United States

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.

$65.0M raised
Sep 2024
Series D
BiotechnologyHealth CarePharmaceuticalTherapeutics

Top Investors

NovartisNational Institutes of HealthNovartis Venture FundJohnson & Johnson Innovation JJDCVisionary Venture Fund

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about ONL Therapeutics

How much funding has ONL Therapeutics raised?
ONL Therapeutics has raised $65.0M in total funding. The most recent round was Series D. The last funding was announced in September 2024.
Who are ONL Therapeutics's investors?
ONL Therapeutics's investors include Novartis, National Institutes of Health, Novartis Venture Fund, Johnson & Johnson Innovation JJDC, Visionary Venture Fund.
Where is ONL Therapeutics headquartered?
ONL Therapeutics is headquartered in Ann Arbor, United States.
What does ONL Therapeutics do?
ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.
What stage is ONL Therapeutics at?
ONL Therapeutics is at the Series D stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"ONL Therapeutics — Funding & Investors." VCBacked, September 13, 2024, https://www.vcbacked.co/company/onl-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2024). ONL Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/onl-therapeutics
Wikipedia (cite web)
{{cite web |title=ONL Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/onl-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong